Jiangsu Recbio Technology Co., Ltd.
HKEX:2179.HK
8.4 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Assets: | |||||
Current Assets: | |||||
Cash & Cash Equivalents
| 834.983 | 1,325.15 | 1,182.562 | 355.821 | 57.239 |
Short Term Investments
| 2.778 | 3.852 | 2.958 | 325.89 | 231.885 |
Cash and Short Term Investments
| 834.983 | 1,325.15 | 1,182.562 | 681.711 | 289.124 |
Net Receivables
| 194.198 | 32.936 | 86.691 | 19.845 | 14.1 |
Inventory
| 93.75 | 56.16 | 23.549 | 7.762 | 7.363 |
Other Current Assets
| 6.442 | 5.674 | 1.769 | 0.058 | 0.063 |
Total Current Assets
| 1,129.373 | 1,419.92 | 1,294.571 | 709.376 | 310.65 |
Non-Current Assets: | |||||
Property, Plant & Equipment, Net
| 1,002.643 | 813.837 | 511.372 | 256.213 | 84.47 |
Goodwill
| 9.305 | 9.305 | 9.305 | 9.305 | 9.305 |
Intangible Assets
| 41.126 | 33.505 | 22.12 | 22.12 | 22.12 |
Goodwill and Intangible Assets
| 50.431 | 42.81 | 31.425 | 31.425 | 31.425 |
Long Term Investments
| 2.4 | 31.404 | 80 | 50 | 0 |
Tax Assets
| -2.4 | -31.404 | -80 | -50 | 0 |
Other Non-Current Assets
| 3.83 | 33.04 | 81.852 | 50 | 0 |
Total Non-Current Assets
| 1,056.904 | 889.687 | 624.649 | 337.638 | 115.895 |
Total Assets
| 2,186.277 | 2,309.607 | 1,919.22 | 1,047.014 | 426.545 |
Liabilities & Equity: | |||||
Current Liabilities: | |||||
Account Payables
| 115.081 | 62.517 | 16.816 | 1.987 | 1.74 |
Short Term Debt
| 61.038 | 21.755 | 7.862 | 4.334 | 3.131 |
Tax Payables
| 0 | 0 | 0.687 | 2.173 | 0.932 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 268.116 | 244.711 | 114.615 | 51.16 | 12.927 |
Total Current Liabilities
| 444.235 | 328.983 | 139.293 | 57.481 | 17.798 |
Non-Current Liabilities: | |||||
Long Term Debt
| 589.757 | 260.872 | 68.857 | 21.791 | 2.398 |
Deferred Revenue Non-Current
| 75.811 | 61.144 | 32.244 | 18.122 | 0 |
Deferred Tax Liabilities Non-Current
| 5.53 | 5.53 | 5.53 | 5.53 | 5.53 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 1,952.874 | 720.366 |
Total Non-Current Liabilities
| 671.098 | 327.546 | 106.631 | 1,998.317 | 728.294 |
Total Liabilities
| 1,115.333 | 656.529 | 245.924 | 2,055.798 | 746.092 |
Equity: | |||||
Preferred Stock
| 0 | 0 | 0 | 1,843.967 | 647.874 |
Common Stock
| 482.963 | 482.963 | 448.25 | 36.069 | 29.356 |
Retained Earnings
| -2,334.288 | -1,753.539 | -1,030.836 | -373.275 | -193.875 |
Accumulated Other Comprehensive Income/Loss
| 393.757 | 349.443 | 301.627 | -1,843.967 | -647.874 |
Other Total Stockholders Equity
| 2,529.004 | 2,583.009 | 1,954.26 | -671.578 | -155.028 |
Total Shareholders Equity
| 1,071.436 | 1,661.876 | 1,673.301 | -1,008.784 | -319.547 |
Total Equity
| 1,070.944 | 1,653.078 | 1,673.296 | -1,008.784 | -319.547 |
Total Liabilities & Shareholders Equity
| 2,186.277 | 2,309.607 | 1,919.22 | 1,047.014 | 426.545 |